Cancer

Capital Increase in Genmab as a Result of Employee Warrant Exercise

Company Announcement COPENHAGEN, Denmark; June 18, 2024 – Genmab A/S (Nasdaq: GMAB) will increase its share capital by 6,986 shares…

3 weeks ago

Mika Health Collaborates with AstraZeneca and Daiichi Sankyo to Deliver AI-Enabled Mobile Support to Women Undergoing Breast Cancer Treatment

Breast cancer patients in Switzerland will receive access to a personalized digital therapeutic designed to optimize their experience and health…

3 weeks ago

“I Have Insurance, Why Can’t I Afford My Oral Anticancer Medications?” International Myeloma Foundation Highlights the Urgent Need for Cancer Drug Parity Act at Congressional Briefing

The Successful Briefing Addressed Insurance Coverage for Oral Anticancer MedicationsWASHINGTON, June 18, 2024 (GLOBE NEWSWIRE) -- The International Myeloma Foundation-led…

3 weeks ago

XBiotech Results from Randomized Double-Blinded Phase 1/2 Study Suggest Potential Breakthrough Treatment for Advanced Pancreatic Cancer

Findings Show Trends for Reduced Toxicities and Better Outcomes for Subjects Receiving ONIVYDE/5-FU Combination and Targeted anti-IL-1alpha TherapyAUSTIN, Texas, June…

3 weeks ago

Biobanking Market size is set to grow by USD 1.66 billion from 2024-2028, growing demand for personalized medicine to boost the market growth, Technavio

NEW YORK, June 19, 2024 /PRNewswire/ -- The global biobanking market  size is estimated to grow by USD 1.66 billion from…

3 weeks ago

Patients for Patient Safety US Announces Patient Safety and Health Equity Summit Highlighting Diagnostic Safety on World Patient Safety Day in Washington DC, Sept. 15-17, 2024

WASHINGTON, DC / ACCESSWIRE / June 18, 2024 / Patients for Patient Safety US (PFPS US) urges Americans impacted by…

3 weeks ago

Cosmo’s Oral Diagnostic Drug Lumeblue(R) Receives Approval of New Drug Application in China

Dublin, Ireland--(Newsfile Corp. - June 18, 2024) - Cosmo Pharmaceuticals N.V. (SIX: COPN) (FSE: C43) (“Cosmo”) reported that its partner…

3 weeks ago

RayStation Used for First-Ever Radiotherapy Treatment with Hitachi’s OXRAY system

STOCKHOLM, June 18, 2024 /PRNewswire/ -- RaySearch Laboratories AB (publ) is pleased to announce a milestone in radiotherapy technology where…

3 weeks ago

Cosmos Health Strengthens Global Brain Tumor Market Position by Entering Agreement to Acquire Remaining Rights to WIPO-Filed CNS Cancer Drug Patent

CHICAGO, IL / ACCESSWIRE / June 18, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified,…

3 weeks ago